The Home Infusion Therapy/Relative Benefit Index: Summary of an Analysis Using Insurance Claims Data

Medical Care

Volumn 36, Issue 5, 1998, Pages 757-765

  Birnbaum, Howard G ^a   Tang, Ming ^b  

^a Analysis Group/Economics   (United States)

^b NONE

Author keywords

Claims data analysis; Health outcomes; Home care; Home infusion therapy; Managed care

Indexed keywords

ARTICLE; BACTERIAL INFECTION; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; INFUSION; INSURANCE; OUTCOME ASSESSMENT; REIMBURSEMENT; STATISTICS; UNITED STATES;

BACTERIAL INFECTIONS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HOME INFUSION THERAPY; INSURANCE CLAIM REVIEW; MANAGED CARE PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); RELATIVE VALUE SCALES; UNITED STATES;

EID: 0032066119     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199805000-00016     Document Type: Article

References (5)

1. Frankel S. NGT + MDS: An Adaptation of the Nominal Croup Technique for Ill-Structured Problems? J Applied Behavioral Science, 1987:23;543.
2. Thickson N. Economics of Home Intravenous Services. PharmacoEconomics 1993;3:220.
3. Kane RE, Jennison K, Wood C, Black PG, Hubst JJ. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol 1988;4:84.
4. Ratain MJ, Weichselbaum RR, Choi KE, Magid DM, Guarnier CM, Whaling SM. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 1989;63:30.
5. Balinsky W, Nesbitt S. Cost effectiveness of outpatient parenteral antibiotics: A review of the literature. Am J Med 1989;87:301.